One in three people who get sick will die.
For the sixteenth time in its recorded history, the Democratic Republic of Congo finds itself in a reckoning with Ebola — this time in the remote reaches of Kasai Province, where the Zaire strain, the most lethal variant known, has claimed at least 28 lives and infected 81 people since August 2025. The outbreak began with a single pregnant woman and spread through the intimate geometries of care and grief that define community life in the region. International health authorities have mobilized swiftly, deploying vaccines and specialists, yet the distance between urgency and capacity remains one of the oldest and most painful distances in global public health.
- The Zaire Ebola strain — capable of killing up to 90% of those it infects — is moving through multiple health zones in remote Kasai Province, with a current fatality rate of 34.5% and no clear ceiling on transmission.
- At least four healthcare workers have died after entering rooms to help patients, and a pregnant woman's death in late August was the spark that ignited a chain of infections now crossing provincial boundaries.
- WHO has deployed 48 specialists and launched ring vaccination with Ervebo — a vaccine shown to be up to 100% effective — but only 400 doses have reached the field so far, against an outbreak already spanning several health zones.
- Cold-chain logistics, poor roads, armed conflict, and scarce protective equipment are slowing the response in a province where remoteness is not just geographic but systemic.
- Kasai's proximity to regional transit hubs and the Angolan border means containment is not only a local challenge — a moderate regional risk assessment signals that the window for preventing wider spread is open but narrowing.
The Democratic Republic of Congo is facing its sixteenth Ebola outbreak, this one rooted in Kasai Province and driven by the Zaire strain — the most lethal variant of the virus. By mid-September, 81 cases had been confirmed and 28 people had died, a fatality rate of roughly 34.5 percent.
The outbreak traces back to a 34-year-old pregnant woman who arrived at Bulape General Reference Hospital on August 20 with fever, hemorrhaging, and profound weakness. She died five days later from multiple organ failure. From that single case, the virus spread to healthcare workers and then into neighboring health zones — Mweka, Mushenge, Dekese — before WHO received formal notification on September 1. Laboratory confirmation followed three days later.
Ebola travels through blood, bodily fluids, and close physical contact. In Kasai, where funeral traditions involve washing and touching the deceased, and where family members gather tightly around the dying, the virus finds its pathways woven into the rhythms of community life. Four healthcare workers have died — people who went in to help and carried the virus out with them.
The response has been rapid. WHO deployed 48 specialists and, alongside DRC authorities, launched ring vaccination using Ervebo — a vaccine with demonstrated efficacy of 84 to 100 percent. Four hundred doses have been distributed, prioritizing contacts of confirmed cases and frontline workers. Alongside vaccination, the response includes case isolation, contact tracing, quarantine, field treatment centers, and clinical care focused on keeping patients alive long enough for their immune systems to respond.
The obstacles are formidable. Kasai is remote, with poor roads, unreliable electricity, and limited cold-chain infrastructure for vaccine delivery. Conflict in the region restricts movement of personnel and supplies. Protective equipment for health workers remains scarce. Genetic analysis suggests the virus entered the human population through an animal spillover rather than from a prior outbreak — a distinction that shapes containment strategy but does not make the work easier.
The province's relative isolation offers some protection against exponential urban spread, but its proximity to regional hubs and the Angolan border keeps broader geographic risk alive. WHO has rated the situation as high national risk, moderate regional risk, and low global risk — a calibration that reflects both the gravity of the outbreak and the current, fragile state of containment. Whether that holds depends on how fast the vaccine reaches people, how thoroughly contact chains can be mapped, and whether the logistical and security barriers can be overcome before the virus moves faster than the response.
The Democratic Republic of Congo is confronting its sixteenth documented Ebola outbreak, this one taking hold in Kasai Province with a speed and reach that has triggered an international response. As of mid-September, health authorities had confirmed 81 cases and 28 deaths—a case fatality rate of roughly 34.5 percent. The culprit is the Zaire strain, the most lethal variant of the virus known to science, capable of killing between a quarter and nine-tenths of those it infects.
The outbreak began in August with a 34-year-old pregnant woman who arrived at Bulape General Reference Hospital in the Boulapé health zone on August 20. She presented with the signature symptoms: high fever, bloody diarrhea, hemorrhaging, and a weakness so profound she could barely move. Five days later, multiple organ failure claimed her life. From that single case, the virus radiated outward. Healthcare workers fell ill. The virus crossed into neighboring health zones—Mweka, Mushenge, Dekese—each one a new frontier of transmission. By the time the World Health Organization received formal alerts on September 1, the outbreak was already moving through the population. Laboratory confirmation came three days later.
The virus spreads through the most intimate of contacts: blood, bodily fluids, the physical closeness that defines care for the dying. In a region where traditional funeral practices involve washing and touching the deceased, where family members gather close to grieve, the pathways of transmission are woven into the fabric of community life. At least four healthcare workers have died—people who entered rooms to help and left carrying the virus home with them.
The response has mobilized quickly. The World Health Organization deployed 48 specialists in surveillance and clinical care. The DRC government, working with WHO and partner organizations, launched what epidemiologists call ring vaccination—a strategy of vaccinating everyone who has had contact with a confirmed case, creating a protective barrier around each infection. The vaccine in use is Ervebo, which demonstrated perfect efficacy in a trial in Guinea when administered immediately after exposure. Real-world data from the 2018-to-2020 outbreak in the DRC itself showed it to be about 84 percent effective. Four hundred doses have been distributed so far, with more on the way. Priority goes to the contacts of confirmed cases and to frontline health workers—the people most likely to encounter the virus and most likely to spread it further.
Beyond vaccination, the response includes the fundamentals of outbreak control: isolating suspected cases as soon as symptoms appear, tracing everyone who has been near them, quarantining those contacts, expanding hospital capacity with field treatment centers. Medical care focuses on keeping patients alive long enough for their immune systems to mount a defense—rehydration, electrolyte replacement, monoclonal antibody treatments that can blunt the virus's assault on the body.
Yet the obstacles are substantial. Kasai Province is remote, and remoteness in the DRC often means poor roads, limited electricity, and distance from supply chains. The vaccines require cold storage, and getting refrigerated cargo to scattered health facilities across a vast territory is a logistical puzzle. Insecurity complicates everything—conflict in the region limits access to some areas and makes it harder to move personnel and supplies. Protective equipment for healthcare workers remains scarce, and the workers themselves are exhausted and afraid.
Genetic analysis suggests this outbreak began with a spillover event—the virus jumping from an animal reservoir to a human, rather than smoldering in the population from a previous outbreak. That distinction matters for understanding how to stop it. Kasai's relative isolation offers some advantage; the virus is not in a major urban center where it could spread exponentially. But the province sits near regional hubs and shares a border with Angola, meaning the risk of broader geographic spread remains real. The WHO has assessed the situation as a high public health risk nationally, moderate regionally, and low globally—a careful calibration that acknowledges both the seriousness of what is happening and the current containment.
What happens next depends on whether the vaccination campaign can reach people fast enough, whether contact tracing can identify chains of transmission before they extend further, and whether the logistical and security challenges can be overcome. The virus is moving. The response is moving too. The outcome remains uncertain.
Citações Notáveis
The outbreak is a high public health risk nationally, moderate regionally, and low globally.— World Health Organization assessment
A Conversa do Hearth Outra perspectiva sobre a história
Why does this outbreak matter now, when the DRC has seen Ebola before?
Because it's the sixteenth time, and each outbreak teaches the virus something new about how to survive in this place. But also because this one started with a pregnant woman—someone whose immune system was already compromised—and spread to healthcare workers. That's the pattern that kills.
The case fatality rate is 34.5 percent. Is that high?
For Ebola, it's actually on the lower end. The Zaire strain can kill nine out of ten people. But 34.5 percent means one in three people who get sick will die. In a place with limited hospitals and no ICUs, that's devastating.
The vaccine sounds like it works. Why isn't this already contained?
Because you have to get the vaccine to people before they get sick, or within days of exposure. In Kasai Province, that means driving refrigerated boxes down roads that barely exist, through areas where armed groups operate. Four hundred doses deployed sounds like a lot until you realize you need thousands more, and they all need cold storage.
What's the difference between this outbreak and the big one in 2018-2020?
That one killed nearly eleven thousand people across three countries. This one is still in one province, still relatively contained. But the conditions that allowed it to spread then—weak health systems, poor roads, distrust of authorities—those conditions haven't changed.
Is Angola at risk?
Yes. The border is porous. If the virus reaches a city on either side, everything changes. That's why WHO is helping neighboring countries prepare, not just DRC.
What happens if the outbreak spreads?
Then you're looking at a regional crisis, not a provincial one. The vaccine works, but only if you can reach people. Once it's in multiple countries, reaching people becomes exponentially harder.